Close
FINDING CURES TOGETHER<sup>SM</sup>

Second AACR International Conference
Translational Cancer Medicine

​Program 

Thursday, Sept. 27, 2018
Welcome and Opening Keynote Lecture
Session 1: Immune Checkpoints
Session 2: Precision Cancer Medicine

Friday, Sept. 28, 2018
Keynote Lecture
Session 3: Epigenetics and Metabolism
Session 4: Translational Research in Leukemia and Lymphoma
Session 5: Ex Vivo Modeling of Cancer
Session 6: Virus-Induced Cancers

Saturday, Sept. 29, 2018
Keynote Lecture
Session 7: The Microbiome and Cancer
Session 8: Steroid-Hormone Receptors and Cancer
Session 9: Tumor Heterogeneity

Thursday, Sept. 27, 2018

Welcome and Opening Keynote Lecture 
1:30-2:30 pm

Welcome and Introduction
Carlos L. Arteaga, UT Southwestern Medical Center, Dallas, Texas

Keynote Lecture
Drew M. Pardoll, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland


Break

2:30-2:45 pm


Session 1: Immune Checkpoints 

2:45-4:15 pm

Targeting regulatory T cells within tumours
Sergio A. Quezada, University College London Cancer Institute, London, England

An innate PD-1 axis potentially influences the response to immunotherapy
Cristina B. Bonorino, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

Immunotherapy for breast cancer: On the horizon
Leisha A. Emens, Johns Hopkins University School of Medicine, Baltimore, Maryland


Break
4:15-4:45 pm

 
Session 2: Precision Cancer Medicine 
4:45-6:15 pm

Implementing precision strategies to address molecular heterogeneity for gastroesophageal adenocarcinoma
Daniel V. Catenacci, University of Chicago, Chicago, Illinois

Precision medicine in patients with metastatic breast cancer
Fabrice André, Institut Gustave Roussy, Villejuif, France

Additional speaker to be announced

Opening Reception
6:15 pm-8:30 pm

Top of page

Friday, Sept. 28, 2018 

Keynote Lecture 
8:45-9:30 am
Session Chair: Carlos Gil M. Ferreira, D'Or Institute for Research and Education, Rio de Janeiro, Brazil

Introduction
Carlos Gil M. Ferreira

Keynote Lecture
Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina


Break
9:30-10 am


Session 3: Epigenetics and Metabolism 
10-11:30 am

Title to be announced
Elizabeth Maher, UT Southwestern Medical Center, Dallas, Texas

Title to be announced
Cynthia A. Zahnow, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Additional speaker to be announced


Break
11:30-11:45 am


Session 4: Translational Research in Leukemia and Lymphoma 
11:45 am-1:15 pm

Title to be announced
Eduardo Sotomayor, George Washington Cancer Center, Washington, DC

Enhancing the function of CAR T cells by optimizing signaling
Marco L. Davila, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Additional speaker to be announced


Poster Session A/Lunch
1:15-3:30 pm


Session 5: Ex Vivo Modeling of Cancer  
3:45-5:15 pm

Title to be announced
Calvin Kuo, Stanford University, Stanford, California

Title to be announced
Maria Romina Girotti, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina

Title to be announced
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, Netherlands


Break
5:15 pm-5:30 pm


Session 6: Virus-Induced Cancers  
5:30-7 pm

Title to be announced
J. Silvio Gutkind, UCSD Moores Cancer Center, La Jolla, California

KSHV-activation of PDGFRA as an oncogenesis driver and therapeutic target in Kaposi’s sarcoma
Enrique A. Mesri, University of Miami Miller School of Medicine, Miami, Florida

Title to be announced
Luisa L. Villa, Fundação Faculdade de Medicina de São Paulo, São Paulo, Brazil


Evening off/Dinner on own
7 pm  

Top of page

Saturday, Sept. 29, 2018 

Keynote Lecture  
8:45 am-9:30 am
Session Chair: Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina

Introduction
Gabriel A. Rabinovich

Keynote Lecture
Luis A. Diaz, Jr., Memorial Sloan Kettering Cancer Center, New York, New York


Session 7: The Microbiome and Cancer  
10-11:30 am

Title to be announced
Jose R. Conejo-Garcia, H. Lee Moffitt Cancer Center and Research Institute, Miami, Florida

Title to be announced
Giorgio Trinchieri, National Cancer Institute, Bethesda, Maryland

Additional speaker to be announced

Break
11:30-11:45 am


Session 8: Steroid-Hormone Receptors and Cancer  
11:45 am-1:15 pm

Title to be announced
Myles Brown, Dana-Farber Cancer Institute, Boston, Massachusetts

Title to be announced
Claudia Lanari, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina

Targeting the bone compartment in metastatic prostate cancer
Nora M. Navone, The University of Texas MD Anderson Cancer Center, Houston, Texas


Poster Session B/Lunch
1:15-3:30 pm


Session 9: Tumor Heterogeneity  
3:30-5 pm

Title to be announced
Jorge S. Reis-Filho, Memorial Sloan Kettering Cancer Center, New York, New York

Title to be announced
Julio A. Aguirre-Ghiso, Icahn School of Medicine at Mount Sinai, New York, New York

Title to be announced
Dirce Maria Carraro, A.C.Camargo Cancer Center, São Paulo, Brazil


Closing Remarks
5:15-5:30 pm

Carlos L. Arteaga, UT Southwestern Medical Center, Dallas, Texas

Carlos Gil M. Ferreira, D'Or Institute for Research and Education, Rio de Janeiro, Brazil

Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina

Top of page